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In the course of a continued investigation of the alkaloid
constituents of the family Amaryllidaceae, 15
Amaryllidaceae alkaloids isolated from Crinum bulbis-
permum and C. moorei were tested for anti-inflammato-
ry activity using cyclooxygenase assay (COX-1 and
COX-2) and antibacterial activity against Bacillus sub-
tilis, Staphylococus aureus, Escherichia coli and
Klebsiella pneumoniae. The alkaloids showed only low
inhibitory activity on COX-1 and COX-2. No bacterial
growth inhibition was observed at the final concentra-
tion of 250μg ml-1 used in this study.
Crinum species (Amaryllidaceae) are used traditionally in
South African folk medicine for rheumatism, backache, sep-
tic sores, abscesses and cold, kidney and bladder infections
(Roberts 1990, Hutchings et al. 1996). The genus Crinum is
a true representative of the family Amaryllidaceae which is
the exclusive source of the Amaryllidaceae alkaloids. The
biological activities associated with these alkaloids covers
analgesic, central nervous system, antiviral, antitumor and
antimalarial effects (Ghosal et al. 1985, Lin et al. 1995,
Campbell et al. 1998). Experiments on the analgesic effects
of these alkaloids, which are attributed to their resemblance
to morphine and codeine skeletons, were carried out exclu-
sively on laboratory animals (Ghosal et al. 1985).
Despite the wide range of biological activities involved,
there have been no reports concerning the activity of these
alkaloids in terms of cyclooxygenese-1 (COX-1) and
cyclooxygenese-2 (COX-2) anti-inflammatory inhibition. In
terms of antibacterial activity there is only a single report
(Viladomat et al. 1996). In the course of our investigation of
the alkaloid constituents of the family Amaryllidaceae, 15
alkaloids were isolated from Crinum bulbispermum [(Brum
f.) Milne-Redh. & Schweick] and C. moorei Hook f.
(Elgorashi et al. 1999, 2001). These were tested for anti-
inflammatory activity using COX-1 and COX-2 and antibac-
terial activity using four bacterial strains.
COX-1 and COX-2 assays were performed as described
by Jäger et al. (1996) and Noreen et al. (1998). Inhibition
refers to reduction of prostaglandin formation in comparison
to untreated samples. Enzyme solution (60μl) and sample
solution (in 12.5% ethanol) were incubated at room tempera-
ture for 5min. The reaction was started by adding 20μl[l-14C]
arachidonic acid (30μM). Samples were incubated for 10min
at 37°C and the reaction terminated by adding 10μl 2N HCl.
Results given are the mean of three experiments. IC50 val-
ues were determined by regression analysis of the results at
three different concentrations of the sample. Positive control
measurements were carried out with indomethacin.
Antibacterial activity was determined using the microtitre
plate method for determining the minimum inhibitory con-
centration of plant extracts (Eloff 1998) with a final concen-
tration of 250μg ml–1. Neomycin was used as a reference
compound. Bacterial strains used were Bacillus subtilis,
Staphylococus aureus, Escherichia coli and Klebsiella pneu-
moniae.
The isolated alkaloids exhibited only very low inhibitory
activity on COX-1 and COX-2 (Table 1). Furthermore, no bac-
terial growth inhibition was observed for any of the alkaloids
under investigation at the final concentration of 250μg ml–1.
Alkaloids are a group of structurally very complex, biolog-
ically, often highly active, and biogenetically diverse natural
products. They have yielded a large number of medically
and/or toxicologically important natural products like mor-
phine, vinca alkaloids and galanthamine (Heinrich 2002). 
The antibacterial and antifungal activities of
Amaryllidaceae plants including Crinum species are well
known (Ghosal et al. 1985). Despite this, none of the alka-
loids tested showed antibacterial and anti-inflammatory
activity. In many studies the biological activity of
Amaryllidaceae extracts was attributed to their non-basic
constituents. For instance, the non-basic extract (hot water
extract) of bulbs of Crinum delagoense yielded an active
compound against BL6 mouse melanoma cells (Nair et al.
1998). The activity shown by water extracts of Clivia
species, Narcissus species and Hymenocalis littoralis was
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explained by the wide occurrence of polyphenolic com-
pounds that are soluble in water (Ieven et al. 1979). In a
recent study in our laboratory on a number of Cyrtanthus
and Gethyllis species, antibacterial and anti-inflammatory
activities were detected in the dichloromethane extracts
(non-basic extracts) rather than the methanolic extracts
where alkaloids were only detected using Dragendorff’s
reagent (unpublished).
In conclusion, the rationale behind uses of Crinum species
in traditional medicine attributed largely to their alkaloid con-
tent needs to be carefully revised and revisited since the
basic constituents showed very low or lack of activity in anti-
inflammatory and antibacterial activity. 
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Table 1: Anti-inflammatory activity of the Amaryllidaceae alkaloids
(500μM) and Indomethacin on COX-1 and COX-2
Compound Inhibitory activity (%)
COX-1 COX-2
8α-ethoxyprecriwelline 11 14
N-desmethyl-8α-ethoxypretazettine 32 0
N-desmethyl-8β-ethoxypretazettine 24 0
Bulbispermine 23 0
1-O-Acetyllycorine 4 0
Epivittatine 17 0
Crinamine 9 0
3-O-Acetylhamayne 17 0
6-Hydroxycrinamine 21 0
Epibuphanisine 4 0
Powelline 4 0
Crinine 16 0
Cherylline 0 0
Crinamidine 10 0
1-Epideacetylbowdensine 3 0
Indomethacin IC50* 62
* At a concentration of 5μM and 200μM on COX-1 and COX-2
respectively
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